|
gut microbiota |
13 |
|
bioavailability |
8 |
|
microbiota |
8 |
|
cross-sectional studies |
7 |
|
fecal enzyme |
7 |
|
l. rhamnosus |
7 |
|
probiotics |
7 |
|
soy isoflavone |
7 |
|
blood pressure monitoring, ambulatory |
6 |
|
deoxynivalenol |
6 |
|
fatty acids |
6 |
|
hypertension |
6 |
|
lactobacillus rhamnosus gg |
6 |
|
sex characteristics |
6 |
|
animals |
5 |
|
obesity |
5 |
|
zearalenone |
5 |
|
aflatoxin b1 |
4 |
|
citrulline |
4 |
|
endocrine disruptor |
4 |
|
female |
4 |
|
humans |
4 |
|
intestinal epithelia |
4 |
|
lactobacillus helveticus |
4 |
|
mice |
4 |
|
microbial metabolites |
4 |
|
polyphenols |
4 |
|
prebiotics |
4 |
|
pregnancy |
4 |
|
rna, messenger - genetics |
4 |
|
transcriptomics |
4 |
|
acute-phase proteins - genetics - metabolism |
3 |
|
aflatoxin |
3 |
|
aflatoxins |
3 |
|
ag |
3 |
|
atherosclerosis |
3 |
|
bacteroides stercoris |
3 |
|
barrier function |
3 |
|
bcaas |
3 |
|
body weight - drug effects |
3 |
|
breast cancer |
3 |
|
cell line |
3 |
|
creatinine - blood |
3 |
|
dietary fiber |
3 |
|
drinking water - administration & dosage |
3 |
|
exopolysaccharide |
3 |
|
fetal exposure |
3 |
|
fumonisin b1 |
3 |
|
gut health |
3 |
|
gut metabolism |
3 |
|
human placental perfusion |
3 |
|
immune system |
3 |
|
immunoenzyme techniques |
3 |
|
inflammation |
3 |
|
intestinal integrity |
3 |
|
intrahepatic triglyceride content |
3 |
|
kidney calculi - chemically induced - prevention & control |
3 |
|
kinetics |
3 |
|
lgg |
3 |
|
lipocalins - genetics - metabolism |
3 |
|
lipopolysaccharides |
3 |
|
macrophage |
3 |
|
melamine renal stone |
3 |
|
membrane proteins - genetics - metabolism |
3 |
|
metal oxides |
3 |
|
mice, inbred c57bl |
3 |
|
microbiota transplantation |
3 |
|
microbiota-directed foods |
3 |
|
mouse |
3 |
|
mucins |
3 |
|
mycotoxin |
3 |
|
nanomaterials |
3 |
|
nanoparticles |
3 |
|
nivalenol |
3 |
|
non-alcoholic fatty liver disease |
3 |
|
ochratoxin a |
3 |
|
oncogene proteins - genetics - metabolism |
3 |
|
osteopontin |
3 |
|
osteopontin - genetics - metabolism |
3 |
|
proteomics |
3 |
|
real-time polymerase chain reaction |
3 |
|
resins, synthetic - toxicity |
3 |
|
resistant starch |
3 |
|
reverse transcriptase polymerase chain reaction |
3 |
|
streptococcus thermophilus |
3 |
|
triazines - toxicity |
3 |
|
urea - blood |
3 |
|
water ingestion |
3 |
|
zno |
3 |
|
adaptive immunity |
2 |
|
advanced glycation endproducts |
2 |
|
aflatoxicol |
2 |
|
aflatoxin b1 - metabolism |
2 |
|
aflatoxins - metabolism |
2 |
|
anti-adhesion effect |
2 |
|
antimicrobial peptides |
2 |
|
antioxidant |
2 |
|
antioxidant capacity |
2 |
|
atp-binding cassette transporters - antagonists & inhibitors |
2 |
|
bacteria translocation |
2 |
|
bacterial translocation |
2 |
|
bariatric surgery |
2 |
|
bile acid |
2 |
|
biological transport - drug effects |
2 |
|
botulinum neurotoxin |
2 |
|
cell integrity |
2 |
|
cell survival - drug effects |
2 |
|
china |
2 |
|
chorionic gonadotropin - secretion |
2 |
|
chromatography, high pressure liquid |
2 |
|
culture media |
2 |
|
cyanuric acid |
2 |
|
cytokine |
2 |
|
cytotoxicity |
2 |
|
dairy products |
2 |
|
defensin |
2 |
|
diet |
2 |
|
environmental exposure |
2 |
|
epigallocatechin-3-gallate |
2 |
|
escherichia coli |
2 |
|
escherichia coli nissle 1917 |
2 |
|
fatty acid metabolism |
2 |
|
fermented milk |
2 |
|
food poisoning |
2 |
|
food-borne bacterial infection |
2 |
|
foodborne infection |
2 |
|
functional food |
2 |
|
fxr |
2 |
|
hdha |
2 |
|
hepatitis b virus |
2 |
|
hepatocellular carcinoma |
2 |
|
hete |
2 |
|
hot temperature |
2 |
|
human |
2 |
|
hydrogen-ion concentration |
2 |
|
hydroxyeicosatetraenoic acid |
2 |
|
immunomodulation |
2 |
|
innate immunity |
2 |
|
intestinal health |
2 |
|
intestinal immune response |
2 |
|
intestinal mucus barrier |
2 |
|
intestinal polyposis |
2 |
|
intestines -- microbiology. |
2 |
|
isoprostane |
2 |
|
isoprostanes |
2 |
|
jeg-3 |
2 |
|
lactic acid bacteria |
2 |
|
lactobacillus |
2 |
|
lactobacillus - metabolism |
2 |
|
lactobacillus rhamnosus |
2 |
|
lc/ms |
2 |
|
liver |
2 |
|
male |
2 |
|
maternal-fetal exchange |
2 |
|
maternal-fetal exchange - drug effects |
2 |
|
membrane transport modulators - pharmacology |
2 |
|
metagenomics |
2 |
|
microarray analysis |
2 |
|
mixture |
2 |
|
mould toxins |
2 |
|
mucin |
2 |
|
mucosal immunity |
2 |
|
multidrug resistance-associated proteins - antagonists & inhibitors |
2 |
|
mycotoxins |
2 |
|
neoplasm proteins - antagonists & inhibitors |
2 |
|
oat beta‐glucan |
2 |
|
oat bran |
2 |
|
oxidative stress |
2 |
|
oxyresveratrol |
2 |
|
p-glycoprotein - antagonists & inhibitors |
2 |
|
perfusion - methods |
2 |
|
placenta |
2 |
|
placenta - blood supply - cytology - drug effects - physiology |
2 |
|
polyunsaturated fatty acid |
2 |
|
pregnancy proteins - antagonists & inhibitors - metabolism - secretion |
2 |
|
pro-inflammatory cytokines |
2 |
|
probiotic |
2 |
|
probiotic bacteria |
2 |
|
probiotics. |
2 |
|
proliferation |
2 |
|
propionibacterium - metabolism |
2 |
|
propionibacterium freudenreichii ssp. shermanii js |
2 |
|
resins, synthetic - metabolism - toxicity |
2 |
|
resveratrol |
2 |
|
species specificity |
2 |
|
systems biology |
2 |
|
tight junction |
2 |
|
transporters |
2 |
|
triazines - metabolism - pharmacology - toxicity |
2 |
|
trichothecenes - metabolism |
2 |
|
trophoblasts - cytology - drug effects - metabolism |
2 |
|
vsl |
2 |
|
(eco)toxicology |
1 |
|
16s sequencing |
1 |
|
2-propanol - pharmacology |
1 |
|
3β-hydroxysteroid dehydrogenase/isomerase |
1 |
|
5-fluorouracil |
1 |
|
5-hydroxymethylfurfural |
1 |
|
absorption |
1 |
|
accumulation |
1 |
|
acrylamide |
1 |
|
acupuncture |
1 |
|
acupuncture therapy - standards |
1 |
|
adducts |
1 |
|
adjuvants, immunologic - administration & dosage - pharmacology |
1 |
|
administration, oral |
1 |
|
adolescent |
1 |
|
adsorption |
1 |
|
adult |
1 |
|
advanced glycation end-products |
1 |
|
aerobic exercise |
1 |
|
aflatoxin b 1-n 7- guanine |
1 |
|
aflatoxin b1 - adverse effects - metabolism |
1 |
|
aflatoxin b1 - analogs & derivatives - metabolism - urine |
1 |
|
aflatoxin b1 - analysis - metabolism |
1 |
|
aflatoxin b1 - chemistry - metabolism - toxicity |
1 |
|
aflatoxin b1 - metabolism - pharmacology |
1 |
|
aflatoxin b1 - metabolism - toxicity |
1 |
|
aflatoxin b1 - urine |
1 |
|
aflatoxin b1-n7-guanine |
1 |
|
aflatoxin m1 |
1 |
|
aflatoxin m1 - analysis - metabolism |
1 |
|
aflatoxin m1 - metabolism |
1 |
|
aflatoxin m1 - urine |
1 |
|
aflatoxin q1 |
1 |
|
aflatoxins - toxicity |
1 |
|
aflatoxins - urine |
1 |
|
albumins - metabolism |
1 |
|
aldafermin |
1 |
|
aloe arborescens |
1 |
|
alternative protein sources |
1 |
|
ames test |
1 |
|
amino acid |
1 |
|
animal model |
1 |
|
animal models (in vivo) |
1 |
|
anti-inflammatory effects |
1 |
|
antibiotic resistance |
1 |
|
anticarcinogenic |
1 |
|
antidiabetic effects |
1 |
|
antifibrogenic |
1 |
|
antigen-presenting cells |
1 |
|
antimutagenic |
1 |
|
antinutritional factors |
1 |
|
antitumor mechanisms |
1 |
|
antitumorigenic effects |
1 |
|
aom/dss model |
1 |
|
apoe-/- mice |
1 |
|
arabidopsis thaliana |
1 |
|
aromatase |
1 |
|
aromatase - genetics - metabolism |
1 |
|
asia |
1 |
|
atp-binding cassette transporters - metabolism |
1 |
|
b-cell receptor |
1 |
|
bacterial adhesion - drug effects |
1 |
|
bacterial infection |
1 |
|
bacterial overgrowth |
1 |
|
bacterial proteins - metabolism |
1 |
|
benzofurans - pharmacology |
1 |
|
beta-glucosidase - antagonists & inhibitors - metabolism |
1 |
|
bg |
1 |
|
bifidobacteria |
1 |
|
bifidobacterium - metabolism |
1 |
|
bifidobacterium breve |
1 |
|
binding |
1 |
|
binding sites |
1 |
|
binding, competitive |
1 |
|
bio-nano reactivity |
1 |
|
bioanalytical method |
1 |
|
biogenic amines |
1 |
|
biological degradation |
1 |
|
biological markers - analysis |
1 |
|
biological markers - urine |
1 |
|
biological transport - physiology |
1 |
|
biomedical research - standards |
1 |
|
biotransformation |
1 |
|
bowel function |
1 |
|
branched-chain amino acids |
1 |
|
breast milk |
1 |
|
butyric acid |
1 |
|
c. elegans |
1 |
|
caco-2 |
1 |
|
caco-2 cells |
1 |
|
cancer suppression |
1 |
|
carbohydrate metabolism |
1 |
|
carcinogens - analysis - metabolism |
1 |
|
carcinogens - metabolism |
1 |
|
carcinogens - pharmacokinetics |
1 |
|
carcinoma, hepatocellular - epidemiology - prevention & control |
1 |
|
cardiovascular disease |
1 |
|
carrier proteins - metabolism |
1 |
|
cattle |
1 |
|
cell cultures (in vitro) |
1 |
|
cell division |
1 |
|
chemoprevention |
1 |
|
chemotherapy |
1 |
|
chemotherapy-induced toxicity |
1 |
|
chickens - metabolism - microbiology |
1 |
|
chickens - microbiology |
1 |
|
children |
1 |
|
chinese herbal medicine |
1 |
|
chromatography |
1 |
|
chromatography - lc/ms |
1 |
|
chronic viral infection |
1 |
|
cirrhosis |
1 |
|
clean-up - affinity columns |
1 |
|
colon |
1 |
|
colon - enzymology - microbiology |
1 |
|
colon cancer |
1 |
|
colonic neoplasms - enzymology - microbiology - prevention & control |
1 |
|
colony count, microbial |
1 |
|
colorectal cancer |
1 |
|
combination |
1 |
|
comet assay |
1 |
|
concanavalin a - pharmacology |
1 |
|
constipation |
1 |
|
cooperative behavior |
1 |
|
cross-over studies |
1 |
|
cyp1a2 |
1 |
|
cyp3a4 |
1 |
|
cytochrome p-450 cyp1a2 - biosynthesis - genetics |
1 |
|
cytochrome p-450 cyp3a |
1 |
|
cytochrome p-450 cyp3a - biosynthesis - genetics |
1 |
|
cytochrome p-450 enzyme system - metabolism |
1 |
|
dairy products - microbiology |
1 |
|
dairying |
1 |
|
decontamination - methods |
1 |
|
dendritic cells |
1 |
|
dextran sulfate sodium induced colitis |
1 |
|
dicarbonyl compounds |
1 |
|
dietary |
1 |
|
dietary carcinogen |
1 |
|
dietary supplements market |
1 |
|
dna |
1 |
|
dna fragmentation - drug effects |
1 |
|
double-blind method |
1 |
|
drug metabolizing enzymes |
1 |
|
drugs, chinese herbal - standards |
1 |
|
dss-induced colitis |
1 |
|
duodenum - metabolism - microbiology |
1 |
|
duodenum - microbiology |
1 |
|
dysbiosis |
1 |
|
eeq test |
1 |
|
egypt |
1 |
|
egypt - epidemiology |
1 |
|
endocrine disruptors - toxicity |
1 |
|
endocrine-disrupting chemicals |
1 |
|
endotoxin |
1 |
|
engineered metal nanoparticles |
1 |
|
enterocytes - microbiology |
1 |
|
enterolactone |
1 |
|
environmental |
1 |
|
enzyme-linked immunosorbent assay |
1 |
|
epidemiological studies |
1 |
|
estrogen equivalency |
1 |
|
estrogenic activity |
1 |
|
estrogenic mycotoxin |
1 |
|
estrogens, non-steroidal - metabolism |
1 |
|
ethanol |
1 |
|
european union |
1 |
|
evidence-based medicine |
1 |
|
exercise responsiveness |
1 |
|
exposure |
1 |
|
extraintestinal cancer |
1 |
|
fecal bacterial enzymes |
1 |
|
fecal transplants |
1 |
|
feces |
1 |
|
feces - chemistry |
1 |
|
feces - enzymology - microbiology |
1 |
|
fermented milk with la. helveticus |
1 |
|
fetal |
1 |
|
fetus |
1 |
|
food |
1 |
|
food contamination |
1 |
|
food fermentation |
1 |
|
food handling - methods |
1 |
|
food ingredients |
1 |
|
food microbiology |
1 |
|
food preservation |
1 |
|
food preservation - methods |
1 |
|
foodborne pathogens |
1 |
|
freeze drying |
1 |
|
fumonisins |
1 |
|
functional foods |
1 |
|
fusarium - chemistry |
1 |
|
fusarium - metabolism |
1 |
|
gas chromatography-mass spectrometry - methods |
1 |
|
gastrointestinal diseases - drug therapy |
1 |
|
gastrointestinal diseases - prevention and control |
1 |
|
gene expression |
1 |
|
genetically modified e.coli nissle 1917 |
1 |
|
genomics |
1 |
|
gi tract barriers |
1 |
|
gi tract microbiota |
1 |
|
glucose metabolism |
1 |
|
glucuronidase - antagonists & inhibitors - metabolism |
1 |
|
glutathione s-transferases |
1 |
|
glutathione transferase - biosynthesis |
1 |
|
gp-tcm |
1 |
|
guanine - analogs & derivatives - urine |
1 |
|
guidelines |
1 |
|
guidelines as topic |
1 |
|
guinea |
1 |
|
gut |
1 |
|
gut microbiome |
1 |
|
gut microbitoa |
1 |
|
hbv |
1 |
|
hcv |
1 |
|
heavy metal |
1 |
|
hepatic stellate cells |
1 |
|
hepatitis b - complications - urine |
1 |
|
hepatitis, viral, human - complications |
1 |
|
hepg2 cells |
1 |
|
herbal medicine |
1 |
|
herbal toxicity |
1 |
|
high-intensity interval training |
1 |
|
high-protein diets |
1 |
|
high-throughput sequencing |
1 |
|
host health |
1 |
|
hydrochloric acid - pharmacology |
1 |
|
hyperuricemia |
1 |
|
immune effects |
1 |
|
immune repertoire |
1 |
|
immunoassays |
1 |
|
immunosuppression |
1 |
|
in vivo |
1 |
|
infants |
1 |
|
inflammatory markers |
1 |
|
inflammatory response |
1 |
|
integrative medicine |
1 |
|
interactome |
1 |
|
intervention |
1 |
|
intestinal absorption - physiology |
1 |
|
intestinal barrier |
1 |
|
intestinal cancer |
1 |
|
intestinal epithelial cells |
1 |
|
intestinal metabolism |
1 |
|
intestinal mucosa - drug effects |
1 |
|
intestinal permeability |
1 |
|
intestine |
1 |
|
intestines - metabolism - microbiology |
1 |
|
intestines - microbiology |
1 |
|
inulin |
1 |
|
isomir |
1 |
|
l-citrulline |
1 |
|
l. helveticus |
1 |
|
lactation |
1 |
|
lactic acid - metabolism |
1 |
|
lactobacilli |
1 |
|
lactobacillus - chemistry - metabolism |
1 |
|
lactobacillus - drug effects - metabolism |
1 |
|
lactobacillus - growth & development - metabolism |
1 |
|
lactobacillus - metabolism - physiology |
1 |
|
lactobacillus acidophilus |
1 |
|
lactobacillus casei |
1 |
|
lactobacillus rhamnosus - metabolism |
1 |
|
lactobacillus rhamnosus - physiology |
1 |
|
lactobacillus rhamnosus lc705 |
1 |
|
lactococci |
1 |
|
lactococcus - classification - growth & development - metabolism |
1 |
|
lactococcus - metabolism |
1 |
|
linear models |
1 |
|
lipid metabolism |
1 |
|
lipopolysaccharides - pharmacology |
1 |
|
liver cancer |
1 |
|
liver diseases |
1 |
|
liver diseases - drug therapy |
1 |
|
liver fibrosis |
1 |
|
liver neoplasms - enzymology - genetics - pathology |
1 |
|
liver neoplasms - epidemiology - prevention & control |
1 |
|
lung |
1 |
|
lymphocyte proliferation |
1 |
|
lymphocytes - cytology |
1 |
|
macrophages |
1 |
|
maternal exposure |
1 |
|
maternal use of drugs |
1 |
|
mechanism of action |
1 |
|
mechanisms of action |
1 |
|
medicine, chinese traditional |
1 |
|
meta-analysis |
1 |
|
metabolism |
1 |
|
metal-based nanoparticle |
1 |
|
methylglyoxal (mgo) |
1 |
|
mhc |
1 |
|
microbiome metabolism |
1 |
|
microcystin |
1 |
|
middle aged |
1 |
|
milk - microbiology |
1 |
|
milk, human - chemistry - metabolism |
1 |
|
mineral availability |
1 |
|
mirna |
1 |
|
mitogen cytotoxicity |
1 |
|
mitogens - pharmacology |
1 |
|
monocyte |
1 |
|
mouse model |
1 |
|
mucin 5ac - genetics |
1 |
|
mucin-5b - genetics |
1 |
|
mucus |
1 |
|
mucus - metabolism - microbiology |
1 |
|
multidrug resistance-associated proteins - metabolism |
1 |
|
mutagens - metabolism |
1 |
|
mycotoxins - toxicity |
1 |
|
mycotoxins - trichothecenes |
1 |
|
n-nitroso compounds |
1 |
|
nafld |
1 |
|
nafld pathogenesis |
1 |
|
neoplasm proteins - metabolism |
1 |
|
non-alcoholic fatty liver disease (nafld) |
1 |
|
non-targeted metabolomics |
1 |
|
non-targeted metabolomics analysis |
1 |
|
ochratoxins - pharmacokinetics |
1 |
|
omics |
1 |
|
omics integration |
1 |
|
oral administration |
1 |
|
organic anion transporters, sodium-independent - metabolism |
1 |
|
ovalbumin - metabolism |
1 |
|
pentosan |
1 |
|
perfusion |
1 |
|
pesticides - toxicity |
1 |
|
pharmacovigilance |
1 |
|
phytotherapy - standards |
1 |
|
pilot projects |
1 |
|
placenta - cytology - enzymology - metabolism |
1 |
|
placenta - metabolism |
1 |
|
placental cytosolic fraction |
1 |
|
placental perfusion |
1 |
|
poisons |
1 |
|
poisons - metabolism - toxicity |
1 |
|
potassium chloride - pharmacology |
1 |
|
potato chips |
1 |
|
poultry |
1 |
|
preeclampsia |
1 |
|
prevalence |
1 |
|
prevention |
1 |
|
probiotic bacterium |
1 |
|
probiotics - administration & dosage |
1 |
|
probiotics - administration & dosage - pharmacology |
1 |
|
probiotics - metabolism |
1 |
|
probiotics - pharmacology - therapeutic use |
1 |
|
propionibacterium - metabolism - physiology |
1 |
|
propionibacterium - physiology |
1 |
|
protein binding |
1 |
|
protein digestibility |
1 |
|
protein fermentation |
1 |
|
protein metabolism |
1 |
|
public health |
1 |
|
random allocation |
1 |
|
rats |
1 |
|
rats, wistar |
1 |
|
reference standards |
1 |
|
reproducibility of results |
1 |
|
resistance training |
1 |
|
risk assessment |
1 |
|
risk factors |
1 |
|
rna sequencing |
1 |
|
rseq |
1 |
|
rutin |
1 |
|
rye bread |
1 |
|
salvianolic acid b |
1 |
|
seasonality |
1 |
|
semi-quantitative |
1 |
|
sensitivity and specificity |
1 |
|
short chain fatty acids |
1 |
|
short-chain fatty acids |
1 |
|
silver nanoparticles |
1 |
|
sodium bicarbonate - pharmacology |
1 |
|
sodium hydroxide - pharmacology |
1 |
|
sonication |
1 |
|
spleen |
1 |
|
spleen - cytology |
1 |
|
sports nutrition |
1 |
|
steroidogenesis |
1 |
|
supplementation |
1 |
|
sus scrofa |
1 |
|
synbiotics |
1 |
|
systematic review |
1 |
|
t-cell receptor |
1 |
|
tea extract |
1 |
|
telmisartan |
1 |
|
temperature |
1 |
|
teratogens - pharmacokinetics |
1 |
|
thailand |
1 |
|
theabrownin |
1 |
|
tight junction proteins |
1 |
|
time factors |
1 |
|
titanium dioxide |
1 |
|
toxicogenomics |
1 |
|
toxicology |
1 |
|
toxicometabonomics |
1 |
|
toxicoproteomics |
1 |
|
toxicotranscriptomics |
1 |
|
toxin binding |
1 |
|
traditional chinese fermented food |
1 |
|
traditional chinese medicine |
1 |
|
transaminases |
1 |
|
transgenic medaka |
1 |
|
translocation |
1 |
|
trichothecenes |
1 |
|
trichothecenes - urine |
1 |
|
trophoblasts - drug effects - enzymology - pathology |
1 |
|
turkey |
1 |
|
turkeys |
1 |
|
type 2 diabetes |
1 |
|
urea - pharmacology |
1 |
|
urease |
1 |
|
urease - antagonists & inhibitors - metabolism |
1 |
|
urine |
1 |
|
vascular inflammation |
1 |
|
victoria |
1 |
|
water - metabolism |
1 |
|
weaning |
1 |
|
weight gain |
1 |
|
wheat bread |
1 |
|
yinchenhao decoction |
1 |
|
young adult |
1 |
|
young men |
1 |
|
zearalenone - chemistry - metabolism |
1 |
|
zearalenone - metabolism |
1 |
|
zebrafish |
1 |
|
zeranol - analogs & derivatives - metabolism |
1 |
|
zinc oxide |
1 |
|
zinc oxide nanoparticles |
1 |
|
β-glucosidase |
1 |
|
β-glucuronidase |
1 |
